These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 2693822)
1. [Study of lymphocyte subpopulations and the expression of activation markers in diabetes mellitus types 1 and 2]. Salozhin KV; Nasonov EL; Sura VV; Aleksandrova EN; Gracheva LA Klin Med (Mosk); 1989 Oct; 67(10):118-21. PubMed ID: 2693822 [TBL] [Abstract][Full Text] [Related]
2. Differences in adhesion markers, activation markers, and TcR in islet infiltrating vs. peripheral lymphocytes in the NOD mouse. Goldrath AW; Barber L; Chen KE; Alters SE J Autoimmun; 1995 Apr; 8(2):209-20. PubMed ID: 7612149 [TBL] [Abstract][Full Text] [Related]
3. Circulating CD4+CD25 high regulatory T cells and natural killer T cells in children with newly diagnosed type 1 diabetes or with diabetes-associated autoantibodies. Oling V; Marttila J; Knip M; Simell O; Ilonen J Ann N Y Acad Sci; 2007 Jun; 1107():363-72. PubMed ID: 17804564 [TBL] [Abstract][Full Text] [Related]
4. [Immunoregulatory disorders and activation of the immune system in dilated cardiomyopathy]. Nasonov EL; Aleksandrova LZ; Samsonov MIu; Aleksandrova EN; Gracheva LA Ter Arkh; 1988; 60(7):25-30. PubMed ID: 2905541 [TBL] [Abstract][Full Text] [Related]
5. [Importance of estimated value of T-cell activation in insulin-dependent diabetes mellitus]. Zhuk EA; Galenok VA Ter Arkh; 1999; 71(4):55-7. PubMed ID: 10358866 [TBL] [Abstract][Full Text] [Related]
6. Different percentages of CD8+ lymphocytes in long-term type 1 diabetics with and without residual beta cell function. Buschard K; Dejgaard A; Madsbad S; Röpke C Diabetes Res; 1989 Nov; 12(3):105-8. PubMed ID: 2699584 [TBL] [Abstract][Full Text] [Related]
7. Autoimmunity to CD38 and GAD in Type I and Type II diabetes: CD38 and HLA genotypes and clinical phenotypes. Antonelli A; Tuomi T; Nannipieri M; Fallahi P; Nesti C; Okamoto H; Groop L; Ferrannini E Diabetologia; 2002 Sep; 45(9):1298-306. PubMed ID: 12242463 [TBL] [Abstract][Full Text] [Related]
8. Age dependency and mutual relations in T and B lymphocyte abnormalities in common variable immunodeficiency patients. Vlková M; Thon V; Sárfyová M; Bláha L; Svobodník A; Lokaj J; Litzman J Clin Exp Immunol; 2006 Feb; 143(2):373-9. PubMed ID: 16412063 [TBL] [Abstract][Full Text] [Related]
9. Occult CD45 T cell developmental defect in type 1 diabetes. Faustman DL Diabete Metab; 1993; 19(5):446-57. PubMed ID: 8056125 [TBL] [Abstract][Full Text] [Related]
10. [Prevalence of type 1 diabetes-specific autoantibodies and of certain HLA patterns in celiac disease]. Schilling I; Conrad K; Füssel M; Henker J Dtsch Med Wochenschr; 2003 Jan; 128(5):185-9. PubMed ID: 12557109 [TBL] [Abstract][Full Text] [Related]
11. [Latent autoimmune diabetes in adults(LADA): part of the clinical spectrum of type-1 diabetes mellitus of autoimmune origin]. Pánczél P; Hosszúfalusi N; Bornemisza B; Horváth L; Jánoskuti L; Füst G; Rajczy K; Vatay A; Prohászka Z; Madácsy L; Luczay A; Blatniczky L; Halmos T; Körner A; Szilvási I; Romics L Orv Hetil; 2001 Nov; 142(46):2571-8. PubMed ID: 11770176 [TBL] [Abstract][Full Text] [Related]
12. [Detection of antibodies against pancreatic islet cells in clinical practice]. Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715 [TBL] [Abstract][Full Text] [Related]
13. [The immunity during the pre-clinical period of type I diabetes mellitus]. Zak KP; Gruzov MA; Afanas'eva VV; Popova VV; Kulikovskaia AV; Semionova TA; Man'kovskiĭ BN Klin Med (Mosk); 2006; 84(8):35-40. PubMed ID: 17087189 [TBL] [Abstract][Full Text] [Related]
14. [Latent autoimmune (type I) diabetes mellitus in adults. Part. II. Association of HLA antigens, status of cellular immunity and occurrence of other autoimmune diseases]. Martinka E; Shawkatová I; Straková J; Buc M; Mokán M Vnitr Lek; 1999 Feb; 45(2):103-9. PubMed ID: 15641229 [TBL] [Abstract][Full Text] [Related]
15. Characterization of immunoregulatory T lymphocytes in insulin-dependent diabetic children by means of monoclonal antibodies. Mascart-Lemone F; Delespesse G; Dorchy H; Lemiere B; Servais G Clin Exp Immunol; 1982 Feb; 47(2):296-300. PubMed ID: 6210472 [TBL] [Abstract][Full Text] [Related]
16. Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients. Itoh N; Hanafusa T; Miyazaki A; Miyagawa J; Yamagata K; Yamamoto K; Waguri M; Imagawa A; Tamura S; Inada M J Clin Invest; 1993 Nov; 92(5):2313-22. PubMed ID: 8227346 [TBL] [Abstract][Full Text] [Related]
17. Expression of activation antigens on lymphocyte surface and circulating platelet-leukocyte aggregates in ischaemic heart disease. Czyz A; Kołacz E; Angerer D; Zawilska K Kardiol Pol; 2005 Mar; 62(3):189-200; discussion 201. PubMed ID: 15830013 [TBL] [Abstract][Full Text] [Related]
18. [The functional activity and count of the natural killer cells in patients with recently diagnosed diabetes mellitus types I and II]. Salozhin KV; Sura VV; Nasonov EL; Korneeva MN; Smirnova OI Ter Arkh; 1989; 61(10):104-6. PubMed ID: 2609254 [TBL] [Abstract][Full Text] [Related]
19. [The cellular immunity indices in diabetic nephropathy]. Salozhin KV; Nasonov EL; Sura VV Ter Arkh; 1991; 63(6):55-8. PubMed ID: 1948748 [TBL] [Abstract][Full Text] [Related]
20. [Heterogeneity of diabetes mellitus]. Asfandiiarova NS; Kolcheva NG; Shatrova IV Ter Arkh; 1999; 71(12):49-52. PubMed ID: 10647203 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]